Recommended Topic Related To:

Fareston

"Nov. 21, 2012 -- Women over age 40 are often urged to get yearly mammograms with the promise that early detection is their best hope for beating breast cancer.

But a new study published in The New England Journal of Medicine su"...

Fareston

Fareston Side Effects Center

Medical Editor: John P. Cunha, DO, FACOEP

Fareston (toremifene citrate) is used to slow the growth of metastatic breast cancer (cancer that has spread from the original tumor). Unlike chemotherapy, this medication does not actually destroy cancer cells. It is an estrogen agonist/antagonist that blocks estrogen from reaching cancer cells. Common side effects include hot flashes, sweating, nausea, vomiting, dry eyes, or dizziness.

The dosage of Fareston is 60 mg, once daily, orally. Treatment is generally continued until disease progression is observed. Fareston may interact with anticoagulants, thiazide diuretics (water pills), or seizure medications. Tell your doctor all medications and supplements you use. During pregnancy, Fareston should be used only when prescribed. It may harm fetus. If you become pregnant or think you may be pregnant, inform your doctor. Women should use 2 forms of birth control while using this medication. Discuss the use of birth control, and the risks and benefits of this medication with your doctor. It is unknown if this medication passes into breast milk. Because of the possible risk to the infant, breastfeeding is not recommended while using this drug.

Our Fareston (toremifene citrate) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What is Patient Information in Detail?

Easy-to-read and understand detailed drug information and pill images for the patient or caregiver from Cerner Multum.

Fareston in Detail - Patient Information: Side Effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Stop using toremifene and call your doctor at once if you have a serious side effect such as:

  • severe dizziness, fainting, fast or pounding heartbeats, seizure (convulsions);
  • nausea, vomiting, stomach pain, loss of appetite, constipation, increased thirst or urination, muscle pain or weakness, joint pain, confusion, and feeling tired or restless;
  • easy bruising, unusual bleeding, purple or red pinpoint spots under your skin;
  • vaginal bleeding or discharge;
  • chest pain or heavy feeling, pain spreading to the arm or shoulder, nausea, sweating, general ill feeling;
  • sudden numbness or weakness, especially on one side of the body;
  • chest pain, sudden cough, wheezing, rapid breathing, coughing up blood;
  • pain, swelling, warmth, or redness in one or both legs;
  • blurred vision, eye pain, or seeing halos around lights;
  • jaundice (yellowing of the skin or eyes);
  • tremor; or
  • loss of movement in any part of your body.

Less serious side effects may include:

  • sweating, hot flashes;
  • mild nausea, constipation;
  • dizziness, spinning sensation;
  • depressed mood;
  • swelling in your hands or feet;
  • itching, skin discoloration; or
  • hair loss.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Read the entire detailed patient monograph for Fareston (Toremifene) »

What is Patient Information Overview?

A concise overview of the drug for the patient or caregiver from First DataBank.

Fareston Overview - Patient Information: Side Effects

SIDE EFFECTS: See also Warning section.

Hot flashes, sweating, nausea, vomiting, dry eyes, or dizziness may occur. If any of these side effects persist or worsen, notify your doctor promptly.

Remember that your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects.

Tell your doctor immediately if any of these unlikely but serious side effects occur: bone/joint/muscle pain or swelling, constipation, mental/mood changes (e.g., depression), trouble walking/clumsiness, swelling ankles/feet, unusual tiredness, vision changes (e.g., blurred vision, eye pain).

Toremifene may increase your risk of uterine cancer. Tell your doctor immediately if you develop changes in menstrual period, unusual vaginal bleeding/discharge or pain/pressure below your "belly button" (navel).

Tell your doctor immediately if any of these rare but very serious side effects occur: easy bleeding/bruising, signs of infection (e.g., fever, chills, persistent sore throat), persistent nausea/vomiting, severe abdominal/stomach pain, dark urine, yellowing eyes/skin.

Toremifene has rarely caused very serious (possibly fatal) blood clots in the lungs/legs, brain (stroke), and heart (heart attack). Seek immediate medical attention if you develop pain/swelling in the groin/calf, pain in the chest/jaw/left arm, confusion, fainting, severe sudden headache, slurred speech, sudden vision changes, shortness of breath, or weakness on one side of the body.

A very serious allergic reaction to this drug is rare. However, seek immediate medical attention if you notice any symptoms of a serious allergic reaction, including: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing.

This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist.

In the US -

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

In Canada - Call your doctor for medical advice about side effects. You may report side effects to Health Canada at 1-866-234-2345.

Read the entire patient information overview for Fareston (Toremifene)»

What is Prescribing information?

The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.

Fareston FDA Prescribing Information: Side Effects
(Adverse Reactions)

SIDE EFFECTS

Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice.

Clinical Trials Experience

Adverse drug reactions are principally due to the antiestrogenic actions of FARESTON and typically occur at the beginning of treatment.

The incidences of the following eight clinical toxicities were prospectively assessed in the North American Study. The incidence reflects the toxicities that were considered by the investigator to be drug related or possibly drug related.

  North American Study
FAR60
n = 221
TAM20
n = 215
Hot Flashes 35% 30%
Sweating 20% 17%
Nausea 14% 15%
Vaginal Discharge 13% 16%
Dizziness 9% 7%
Edema 5% 5%
Vomiting 4% 2%
Vaginal Bleeding 2% 4%

Approximately 1% of patients receiving FARESTON (n = 592) in the three controlled studies discontinued treatment as a result of adverse reactions (nausea and vomiting, fatigue, thrombophlebitis, depression, lethargy, anorexia, ischemic attack, arthritis, pulmonary embolism, and myocardial infarction).

Serious adverse reactions occurring in at least 1% of patients receiving FARESTON in the three major trials are listed in the table below.

Three prospective, randomized, controlled clinical studies (North American, Eastern European, and Nordic) were conducted. The patients were randomized to parallel groups receiving FARESTON 60 mg (FAR60) or tamoxifen 20 mg (TAM20) in the North American Study or tamoxifen 40 mg (TAM40) in the Eastern European and Nordic studies. The North American and Eastern European studies also included high-dose toremifene arms of 200 and 240 mg daily, respectively [see Clinical Studies].

Adverse Reactions North American Eastern European Nordic
FAR 60
n=221 (%)
TAM 20
n=215 (%)
FAR 60
n=157 (%)
TAM 40
n=149 (%)
FAR 60
n=214 (%)
TAM 40
n=201 (%)
Cardiac
Cardiac Failure 2 (1) 1 ( < 1) -   1 ( < 1) 2 (1) 3 (1.5)
Myocardial Infarction 2 (1) 3 (1.5) 1 ( < 1) 2 (1) -   1 ( < 1)
Arrhythmia -   -   -   -   3 (1.5) 1 ( < 1)
Angina Pectoris -   -   1 ( < 1) -   1 ( < 1) 2 (1)
Ocular*
Cataracts 22 (10) 16 (7.5) -   -   -   5 (3)
Dry Eyes 20 (9) 16 (7.5) -   -   -   -  
Abnormal Visual Fields 8 (4) 10 (5) -   -   -   1 ( < 1)
Corneal Keratopathy 4 (2) 2 (1) -   -   -   -  
Glaucoma 3 (1.5) 2 (1) 1 ( < 1) -   -   1 ( < 1)
Abnormal Vision/Diplopia -   -   -   -   3 (1.5) -  
Thromboembolic
Pulmonary Embolism 4 (2) 2 (1) 1 ( < 1) -   -   1 ( < 1)
Thrombophlebitis -   2 (1) 1 ( < 1) 1 ( < 1) 4 (2) 3 (1.5)
Thrombosis -   1 ( < 1) 1 ( < 1) -   3 (1.5) 4 (2)
CVA/TIA 1 ( < 1) -   -   1 ( < 1) 4 (2) 4 (2)
Elevated Liver Tests**
AST 11 (5) 4 (2) 30 (19) 22 (15) 32 (15) 35 (17)
Alkaline Phosphatase 41 (19) 24 (11) 16 (10) 13 (9) 18 (8) 31 (15)
Bilirubin 3 (1.5) 4 (2) 2 (1) 1 ( < 1) 2 (1) 3 (1.5)
Hypercalcemia 6 (3) 6 (3) 1 ( < 1) -   -   -  
* Most of the ocular abnormalities were observed in the North American Study in which on-study and biannual ophthalmic examinations were performed. No cases of retinopathy were observed in any arm.
** Elevated defined as follows: North American Study: AST > 100 IU/L; alkaline phosphatase > 200 IU/L; bilirubin > 2 mg/dL. Eastern European and Nordic studies: AST, alkaline phosphatase, and bilirubin - WHO Grade 1 (1.25 times the upper limit of normal).

Other adverse reactions included leukopenia and thrombocytopenia, skin discoloration or dermatitis, constipation, dyspnea, paresis, tremor, vertigo, pruritus, anorexia, reversible corneal opacity (corneal verticulata), asthenia, alopecia, depression, jaundice, and rigors.

The incidence of AST elevations was greater in the 200 and 240 mg FARESTON dose arms than in the tamoxifen arms. Higher doses of FARESTON were also associated with an increase in nausea.

Approximately 4% of patients were withdrawn for toxicity from the high-dose FARESTON treatment arms. Reasons for withdrawal included hypercalcemia, abnormal liver function tests, and one case each of toxic hepatitis, depression, dizziness, incoordination, ataxia, blurry vision, diffuse dermatitis, and a constellation of symptoms consisting of nausea, sweating, and tremor.

Post-marketing Experience

The following adverse reactions were identified during post approval use of FARESTON. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.

Adverse reactions reported during post approval use of FARESTON have been consistent with clinical trial experience. The most frequently reported adverse reactions related to FARESTON use since market introduction include hot flash, sweating, nausea, and vaginal discharge.

Read the entire FDA prescribing information for Fareston (Toremifene) »

A A A

Fareston - User Reviews

Fareston User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Fareston sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Breast Cancer

Find support and advances in treatment.